Tinghui Duan1†
Diyuan Zhou
Xinyu Shao
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Department of Medical Imaging, The Affiliated Guangji Hospital of Soochow University, Suzhou, China
- 2Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China
- 3Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China
A Corrigendum on:
The Association of Aberrant Expression of FGF1 and mTOR-S6K1 in Colorectal Cancer
by Duan T, Zhou D, Yao Y and Shao X (2021) Front. Oncol. 11:706838. doi: 10.3389/fonc.2021.706838
In the original article, there was a mistake in Figure 7B as published. We identified a minor error in image-misusing was made. The corrected Figure 7 appears below.
FIGURE 7
Figure 7 FGF1 promotes proliferation and migration ability of CRC cells. (A, B) Colony formation capacity (A) and migration rates (B) of FGF1-KD CRC cells. CRC, colorectal cancer. (C) Wound healing assays were carried out at 24h after transfection in 6-well plates. The gap width was measured using Open Lab software. (D) The wound rate was calculated and displayed graphically according to the measured results by Open Lab software. NC, negative control; KD, FGF1-shRNA. Data are presented as mean ± SD (n=3). Ns, no significance, *P < 0.05.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: colorectal cancer, FGF1, mTOR-S6K1 pathway, prognosis, survival
Citation: Duan T, Zhou D, Yao Y and Shao X (2021) Corrigendum: The Association of Aberrant Expression of FGF1 and mTOR-S6K1 in Colorectal Cancer. Front. Oncol. 11:792453. doi: 10.3389/fonc.2021.792453
Received: 10 October 2021; Accepted: 11 October 2021;
Published: 25 October 2021.
Edited and reviewed by:
Alessandro Passardi, Romagnolo Scientific Institute for the Study and Treatment of Tumors (IRCCS), ItalyCopyright © 2021 Duan, Zhou, Yao and Shao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xinyu Shao, eGlueGlueXV4aW4wNzExQDE2My5jb20=; Yizhou Yao, eXp5YW9Ac3VkYS5lZHUuY24=
†These authors have contributed equally to this work